Mark Galeotti Mark Galeotti

Why Merkel and Putin are cooperating on the Sputnik vaccine

Angela Merkel and Vladimir Putin (Photo: Getty)

Churchill, FDR and Stalin could cooperate against Hitler, so perhaps we shouldn’t be too surprised that even amidst talk of a new Cold War, sanctions and more than a little sanctimony, people in the West are willing to make deals with Moscow in the name of fighting the new global threat, Covid-19.

Russia’s Sputnik V vaccine may have been rushed through its certification at home and been the subject of some overblown nationalist hype (not that the Oxford-AstraZeneca vaccine has been entirely free of the latter), but so far it appears to be a serious and effective jab, with a potential 91.4 per cent efficacy. Although based on a different source of modified adenovirus, a common cold virus, it is similar in many ways to the Oxford-AstraZeneca vaccine, not least in that it is relatively cheap and can be stored in a regular fridge.

There is still widespread suspicion about the vaccine in Russia, where over a million have received the first of their two jabs, but several other countries have leapt at the chance to use or license Sputnik V, including Algeria, Brazil, China, and India.

Not in the West, though.

Mark Galeotti
Written by
Mark Galeotti

Mark Galeotti heads the consultancy Mayak Intelligence and is honorary professor at the UCL School of Slavonic and East European Studies and the author of some 30 books on Russia. His latest, Forged in War: a military history of Russia from its beginnings to today, is out now.

Topics in this article

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in